Yang; Zhi-Qiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yang; Zhi-Qiang.The latest application filed is for "verifying method for ecc circuit of sram".

Company Profile

0.17.21

Yang; Zhi-Qiang - Hsinchu TW
Yang; Zhi-Qiang - Westfield NJ
Yang; Zhi-Qiang - Schwenksville PA
Yang; Zhi-Qiang - West Point PA US
Yang; Zhi-Qiang - Sumneytown Pike PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Verifying Method For Ecc Circuit Of Sram App 20220283897 - Yang; Zhi-Qiang ; et al.	2022-09-08
Preparation and Use of Cyclic Sulfonamide Derivatives as PAR-1 Receptor Antagonists App 20170240539 - Stamford; Andrew W. ; et al.	2017-08-24
Quinoline Amide M1 Receptor Positive Allosteric Modulators App 20160075656 - Kuduk; Scott D. ; et al.	2016-03-17
N-linked lactam M1 receptor positive allosteric mogulators Grant 9,206,200 - Kuduk , et al. December 8, 2	2015-12-08
Quinoline amide M1 receptor positive allosteric modulators Grant 9,199,939 - Kuduk , et al. December 1, 2	2015-12-01
Oxazole derivatives useful as modulators of FAAH Grant 9,073,879 - Nantermet , et al. July 7, 2	2015-07-07
Heterocycle amide T-type calcium channel antagonists Grant 8,987,310 - Barrow , et al. March 24, 2	2015-03-24
N-linked Lactam M1 Receptor Positive Allosteric Modulators App 20150065498 - Kuduk; Scott D. ; et al.	2015-03-05
N-linked quinolineamide M1 receptor positive allosteric modulators Grant 8,940,765 - Kuduk , et al. January 27, 2	2015-01-27
N-linked Quinolineamide M1 Receptor Positive Allosteric Modulators App 20140200222 - Kuduk; Scott D. ; et al.	2014-07-17
Isoindolone M1 receptor positive allosteric modulators Grant 8,697,690 - Beshore , et al. April 15, 2	2014-04-15
Heterocycle phenyl amide T-type calcium channel antagonists Grant 8,637,513 - Barrow , et al. January 28, 2	2014-01-28
Isoindolone M1 Receptor Positive Allosteric Modulators App 20130109686 - Beshore; Douglas C. ; et al.	2013-05-02
Oxazole Derivatives Useful As Modulators Of Faah App 20130012526 - Nantermet; Philippe G. ; et al.	2013-01-10
Quinoline Amide M1 Receptor Positive Allosteric Modulators App 20120252808 - Kuduk; Scott D. ; et al.	2012-10-04
Pyridyl amide T-type calcium channel antagonists Grant 8,263,627 - Barrow , et al. September 11, 2	2012-09-11
Heterocycle Amide T-type Calcium Channel Antagonists App 20120202852 - Barrow; James ; et al.	2012-08-09
Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease Grant 8,114,887 - Barrow , et al. February 14, 2	2012-02-14
Pyridyl Amide T-Type Calcium Channel Antagonists App 20110112064 - Barrow; James C. ; et al.	2011-05-12
Pyridyl amide T-type calcium channel antagonists Grant 7,875,636 - Barrow , et al. January 25, 2	2011-01-25
Heterocycle Phenyl Amide T-type Calcium Channel Antagonists App 20100261724 - Barrow; James C. ; et al.	2010-10-14
Heterocycle Amide T-type Calcium Channel Antagonists App 20100249176 - Barrow; James C. ; et al.	2010-09-30
3-Fluoro-Piperidine T-Type Calcium Channel Antagonists App 20100222387 - Barrow; James C. ; et al.	2010-09-02
Pyrazinyl Amide-t Type Calcium Channel Antagonists App 20100216816 - Barrow; James C. ; et al.	2010-08-26
Quinazolinone T-Type Calcium Channel Antagonists App 20100210671 - Barrow; James C. ; et al.	2010-08-19
Pyridyl Amide T-Type Calcium Channel Antagonists App 20090275550 - Barrow; James C. ; et al.	2009-11-05
Novel Macrocycles and Uses Thereof App 20080108694 - Danishefsky; Samuel J ; et al.	2008-05-08
Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer' s disease App 20070197571 - Barrow; James C. ; et al.	2007-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.